Evaxion A EVAX
NASDAQ EVAX
$2.75 -0.25 (-8.33%)
At close: Nov 9, 2026 · 4:00 PM EST

Evaxion A (EVAX) Net Equity Issued and Repurchased (2021)

Updated

Evaxion A (EVAX) recorded Net Equity Issued and Repurchased of $2.59 million in FY2023.

Analysis

Evaxion A (EVAX) Net Equity Issued and Repurchased (2021) Analysis & Trends

Starting with FY2018, Evaxion A's Net Equity Issued and Repurchased history includes 4 years.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 18.8% (FY2018 to FY2023).
  • The FY2023 figure is the highest annual Net Equity Issued and Repurchased since FY2020.
  • Per Business Quant data, EVAX's Net Equity Issued and Repurchased was $9.02 million in FY2020 (-4.5%) and $9.44 million in FY2019 (+764.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -966.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -5.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -283.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Evaxion A 17.56 Mn -48.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 27.90 Mn
API Access

Evaxion A Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EVAX&period=max&api_key=YOUR_API_KEY